87 episodes

A podcast focused on the medical device technology industry, from design and development to outsourcing services and relationships to finished medtech products.

Medtech Matters Medical Product Outsourcing

    • Health & Fitness
    • 4.8 • 4 Ratings

A podcast focused on the medical device technology industry, from design and development to outsourcing services and relationships to finished medtech products.

    Discussing Asensus Surgical’s Senhance Robotic Surgical System

    Discussing Asensus Surgical’s Senhance Robotic Surgical System

    In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Anthony Fernando, the president and CEO of Asensus Surgical. He talks about his company’s Senhance robotic surgical system and how it stands apart from competitors. In addition, he discusses the integration of artificial intelligence and machine learning within robotic surgical technologies. Specifically, the following questions are addressed.


    Your company offers the Senhance Surgical System. Can you tell me what that is?We’re seeing an emergence of robotic surgical systems in healthcare. What differentiates the Senhance System?What role is AI and machine learning playing in robotic surgical systems?I mentioned the emergence of robotic surgical solutions we are seeing. Why is that? What’s driving this segment?What’s ahead for robotic surgical systems? Where is this sector headed in five years?
    Listen to this episode and see what you think of the Senhance system. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

    • 19 min
    Top 483s of 2020

    Top 483s of 2020

    In this Medtech Matters podcast episode of Mike on Medtech with Mike Drues, president of Vascular Sciences, we discuss the 483s medical device manufacturing facilities received in 2020. The list comes from the FDA and points to trends among device manufacturers that the quality systems companies have in place may not be used adequately. Actions to take to avoid such concerns in the future are addressed as well as best practices device makers should consider. Specifically, the following questions are addressed:


    If every company is required to have a quality management system in place, how does this happen?Is there something to be said about the FDA’s numbers given how many companies are registered with the FDA for the manufacture of medical devices?So if CAPA, complaint handling, and design controls represent approximately a third of the 483s issued in 2020, what are the other two thirds.What are your tips and suggestions for companies to avoid these types of citations?Do you think the pandemic had any impact on these numbers? Were some companies ill-prepared for a virtual inspection with the FDA?
    Listen to this episode and see what you think of the top 483s in 2020. If you’d like to share thoughts, ask questions, or have a suggestion for a future topic for us to cover, please reach out to me at sfenske@rodmanmedia.com and we’ll see if we want to address your ideas/inquiries/suggestions in a future episode.

    • 29 min
    Legacy DNA’s Market Strategy Advice

    Legacy DNA’s Market Strategy Advice

    In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Dr. Roxie Mooney, the CEO and Healthcare Commercialization Strategist of Legacy DNA. She shares a number of best practices for companies determining their pathway to market for a new medical device. She also shares ideas and strategies for how medical device manufacturers can better leverage marketing channels to target a specific audience. Specifically, the following questions are addressed.


    What is Legacy DNA and how are you helping medical device manufacturers?What’s the biggest or most common mistake you see with regard to a company’s market strategy?What are some of your best suggestions for getting to market and gaining market share?How did the pandemic disrupt device manufacturers’ pathway to market?Do you anticipate any lasting changes with regard to a firm getting to market or do you expect an eventual return to business as usual?
    Listen to this episode and see what you think of the suggestions provided and how they could affect your market startegy. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

    • 29 min
    NeuTigers’ Edge-Based AI for Healthcare

    NeuTigers’ Edge-Based AI for Healthcare

    In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Dr. Greg Nicola, the chief medical officer at NeuTigers. He shares information about the firm’s involvement with Princeton University and the neural networks they are leveraging for use in the medical space. Further, he discusses why the use of this technology on edge devices is a differentiator for AI. Specifically, the following questions are addressed.


    What is NeuTigers?What is meant by shrinking AI?How is this being used within the healthcare space?Do you have real world examples of it being used?What are the next steps for this technology within healthcare? Do you have other clinical areas on your radar that you’d like to address?
    Listen to this episode and see what you think of the NeuTigers, neural networks, and the use of AI on edge devices. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

    • 19 min
    Medtronic's Pillcam and GI Genius

    Medtronic's Pillcam and GI Genius

    In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Giovanni Di Napoli, president of Gastrointestinal at Medtronic. He shares insights on several of Medtronic’s gastrointestinal diagnostic devices, including the Pillcam—a pill-sized camera a patient swallows to gain views of the digestive tract. The device provides an alternative to a colonoscopy as a first-step procedure. Additionally, Di Napoli gives information about the capabilities of the AI-driven GI Genius technology. Specifically, the following questions are addressed.


    What types of medical technology does Medtronic offer through its Gastrointestinal unit?Let’s focus specifically on the Pillcam. What is this technology and is it an alternative to a colonoscopy?Given the movement to expand telehealth we are seeing as one result of the pandemic, how does this align with the functionality and benefits of the Pillcam?Why is Medtronic teaming up with Amazon around the Pillcam at home program and what are the goals of this collaboration?What is GI Genius and how does it tie to the Pillcam?Any chance you can give us any type of scoop on the next steps for the GI Genius technology?
    Listen to this episode and see what you think of the industry’s response to the need for COVID diagnostics. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

    • 16 min
    COVID Diagnostics from Beckman Coulter

    COVID Diagnostics from Beckman Coulter

    In this episode of Medtech Matters, a podcast focused on the medical device manufacturing industry and the factors impacting it, we speak with Chris Hagen, vice president of the global COVID-19 task force and marketing for Beckman Coulter. He addresses a number of issues around the COVID-19 pandemic, from challenges with the ramp-up of production to securing needed supplies from a supply chain under stress. Hagen also speaks to the federal government’s response and how it affected diagnostic manufacturers. Specifically, the following questions are addressed.


    For those who don’t know what Beckman Coulter is, can you give a brief introduction?How has Beckman Coulter contributed to the fight against COVID-19?What was it like for a firm like Beckman Coulter to scale up manufacturing to meet the incredible demand for COVID-19 diagnostics?What was the impact of all those tests on the diagnostic infrastructure, such as the processing labs, and were the manufacturers able to aid with this portion in any way?How is the federal government trying to increase testing capability and what’s the impact on manufacturers?For Beckman Coulter, what are the lessons learned from the pandemic that you can carry forward?
    Listen to this episode and see what you think of the industry’s response to the need for COVID diagnostics. If you’d like to share thoughts, ask questions, or suggest a future participant for Medtech Matters, please reach out to me at sfenske@rodmanmedia.com.

    • 23 min

Customer Reviews

4.8 out of 5
4 Ratings

4 Ratings

malfoxley ,

Great show!

The hosts of the Medtech matters podcast, highlight all aspects of med tech and more in this can’t miss podcast! The hosts and expert guests offer insightful advice and information that is helpful to anyone that listens!

medtech professional ,

CEO

A lot of useful information for medtech professionals!!

Top Podcasts In Health & Fitness

Listeners Also Subscribed To